Compare VRSK & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRSK | DGX |
|---|---|---|
| Founded | 1971 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0B | 22.6B |
| IPO Year | 2008 | 1996 |
| Metric | VRSK | DGX |
|---|---|---|
| Price | $183.42 | $203.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $259.38 | $214.38 |
| AVG Volume (30 Days) | ★ 1.8M | 653.1K |
| Earning Date | 04-29-2026 | 04-21-2026 |
| Dividend Yield | 1.06% | ★ 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | 1.73 | ★ 2.24 |
| Revenue | N/A | ★ $11,035,000,000.00 |
| Revenue This Year | $6.68 | $7.53 |
| Revenue Next Year | $6.74 | $3.77 |
| P/E Ratio | $105.21 | ★ $90.89 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $155.94 | $164.65 |
| 52 Week High | $314.80 | $213.50 |
| Indicator | VRSK | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 58.39 | 62.38 |
| Support Level | $160.75 | $200.94 |
| Resistance Level | $191.51 | $205.00 |
| Average True Range (ATR) | 5.70 | 4.21 |
| MACD | 1.12 | 1.19 |
| Stochastic Oscillator | 88.92 | 73.13 |
Verisk is a leading data, analytics, and technology provider for property-casualty insurers. Verisk traces its history to Insurance Services Office, a nonprofit advisory organization founded in 1971 by US P&C insurers. ISO was formed as an association of insurance companies to assist with a variety of insurance use cases, such as reporting to regulators, defining policies, and determining independent premium rates. As the firm expanded its use cases, it became a for-profit company, renamed Verisk, and went public in 2009. Verisk's single segment (insurance) provides underwriting solutions, including forms, rules, loss costs, and catastrophe modeling. For claims, Verisk's solutions include property repair estimates and antifraud tools. About 83% of Verisk's revenue is US-based.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.